相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of laropiprant on nicotinic acid-induced flushing in patients with dyslipidemia
John F. Paolini et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Lipid management to reduce cardiovascular risk - A new strategy is required
H. Robert Superko et al.
CIRCULATION (2008)
Promise of low-density lipoprotein-lowering therapy for primary and secondary prevention
Scott M. Grundy
CIRCULATION (2008)
Current status of cholesterol goal attainment after statin therapy among patients with hypercholesterolemia in Asian countries and region: the Return on Expenditure Achieved for Lipid Therapy in Asia (REALITY-Asia) study
Hyo-Soo Kim et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Fully automated closed-loop insulin delivery versus sermautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas
Stuart A. Weinzimer et al.
DIABETES CARE (2008)
Lipid-altering efficacy of ezetimibe/simvastatin 10/40 mg compared with doubling the statin dose in patients admitted to the hospital for a recent coronary event: the INFORCE study
J. P. D. Reckless et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
ENHANCE: food for the ostriches
G. Jackson
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
Critical lessons from the ENHANCE trial
Philip Greenland et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes - The SANDS randomized trial
Barbara V. Howard et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients - The MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY II) trial
Christie M. Ballantyne et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Promise of improving metabolic and lifestyle risk in practice
Dariush Mozaffarian
LANCET (2008)
Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial
D. A. Wood et al.
LANCET (2008)
Statins and diabetes - Reply
Patricia M. Kearney et al.
LANCET (2008)
Effects of niacin on glucose control in patients with dyslipidemia
Ronald B. Goldberg et al.
MAYO CLINIC PROCEEDINGS (2008)
Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis
Anne B. Rossebo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Simvastatin with or without ezetimibe in familial hypercholesterolemia
John J. P. Kastelein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe-statin therapies on non-cholesterol sterols in patients with primary hypercholesterolemia
Gerd Assmann et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
European guidelines on cardiovascular disease prevention in clinical practice: executive summary
Ian Graham et al.
EUROPEAN HEART JOURNAL (2007)
The use of colesevelam hydrochloride in the treatment of dyslipidemia: a review
Michael H. Davidson
EXPERT OPINION ON PHARMACOTHERAPY (2007)
Intensive statin therapy in acute coronary syndromes and stable coronary heart disease: a comparative meta-analysis of randomised controlled trials
Jonathan Afilalo et al.
HEART (2007)
Efficacy of ezetimibe/simvastatin 10/20 and 10/40 mg compared with atorvastatin 20 mg in patients with type 2 diabetes mellitus
C. Constance et al.
DIABETES OBESITY & METABOLISM (2007)
Suppression of niacin-induced vasodilation with an antagonist to prostaglandin D2 receptor subtype 1
E. Lai et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Discontinuation of lipid modifying drugs among commercially insured United States patients in recent clinical practice
Sachin J. Kamal-Bahl et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction
Jeppe N. Rasmussen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Contemporary diagnosis and management of hypercholesterolemia in elderly acute myocardial infarction patients: A population-based study
Alan K. Berger et al.
AMERICAN JOURNAL OF GERIATRIC CARDIOLOGY (2007)
Lipid-modifying therapy and attainment of cholesterol goals in Hungary - The return on expenditure achieved for lipid therapy (REALITY) study
Gyoergy Paragh et al.
CLINICAL DRUG INVESTIGATION (2007)
European guidelines on cardiovascular disease prevention in clinical practice: Full text
Ian Graham et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2007)
Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol - A randomized controlled trial
Jeannie K. Lee et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Lipid-lowering effects of colesevelam HCl in combination with ezetimibe
Harold Bays et al.
CURRENT MEDICAL RESEARCH AND OPINION (2006)
Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients
Alberico L. Catapano et al.
CURRENT MEDICAL RESEARCH AND OPINION (2006)
The effect of early, intensive statin therapy on acute coronary syndrome - A meta-analysis of randomized controlled trials
Eddie Hulten et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Prediction of major adverse cardiovascular events by age-normalized carotid intimal medial thickness
Yasmine S. Ali et al.
ATHEROSCLEROSIS (2006)
Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes - The treating to new targets (TNT) study
James Shepherd et al.
DIABETES CARE (2006)
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update - Endorsed by the National Heart, Lung, and Blood Institute
Sidney C. Smith et al.
CIRCULATION (2006)
Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia
HE Bays et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Overcoming 'ageism' bias in the treatment of hypercholesterolaemia - A review of safety issues with statins in the elderly
Terry A. Jacobson
DRUG SAFETY (2006)
Familial hypercholesterolemia: A challenge of diagnosis and therapy
C Sibley et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2006)
Lipid-altering efficacy of switching from atorvastatin 10 mg/day to ezetimibe/simvastatin 10/20 mg/day compared to doubling the dose of atorvastatin in hypercholesterolaemic patients with atherosclerosis or coronary heart disease
V Barrios et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2005)
Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients -: The PRIMO study
E Bruckert et al.
CARDIOVASCULAR DRUGS AND THERAPY (2005)
High-dose atorvastatin vs usual dose simvastatin for secondary prevention after myocardial infarction - The IDEAL study: A randomized controlled trial
TR Pedersen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Lipid-modifying therapy and attainment of cholesterol goals in Europe: the Return on Expenditure Achieved for Lipid Therapy (REALITY) study
E Van Ganse et al.
CURRENT MEDICAL RESEARCH AND OPINION (2005)
Results of the National Cholesterol Education (NCEP) Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations
MH Davidson et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Effect of co-administering ezetimibe with on-going simvastatin treatment on LDL-C goal attainment in hypercholesterolemic patients with coronary heart disease
M Farnier et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2005)
Efficacy and safety of ezetimibe co-administered with ongoing atorvastatin therapy in achieving low-density lipoprotein goal in patients with hypercholesterolemia and coronary heart disease
JM Cruz-Fernández et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2005)
LDL-C goal attainment with the addition of ezetimibe to on-going simvastatin treatment in coronary heart disease patients with hypercholesterolemia
C Brohet et al.
CURRENT MEDICAL RESEARCH AND OPINION (2005)
Prevention and Rehabilitation - Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: The Vytorin Versus Atorvastatin (VYVA) Study
CM Ballantyne et al.
AMERICAN HEART JOURNAL (2005)
Intensive versus moderate lipid lowering with statins after acute coronary syndromes
CP Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis - A randomized controlled trial
SE Nissen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes - Phase Z of the A to Z trial
JA de Lemos et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
HM Colhoun et al.
LANCET (2004)
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
SM Grundy et al.
CIRCULATION (2004)
Efficacy of extended-release niacin with lovastatin for hypercholesterolemia - Assessing all reasonable doses with innovative surface graph analysis
W Insull et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Follow-up lipid tests and physician visits are associated with improved adherence to statin therapy
JS Benner et al.
PHARMACOECONOMICS (2004)
Adherence to and dosing of β-hydroxy-β-methylglutaryl coenzyme A reductase inhibitors in the general population differs according to apolipoprotein E-genotypes
AH Maitland-van der Zee et al.
PHARMACOGENETICS (2003)
Ineffective decrease of serum cholesterol by simvastatin in a subgroup of hypercholesterolemic coronary patients
TA Miettinen et al.
ATHEROSCLEROSIS (2002)
Long-term persistence in use of statin therapy in elderly patients
JS Benner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Adherence with statin therapy in elderly patients with and without acute coronary syndromes
CA Jackevicius et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial
R Collins et al.
LANCET (2002)
Long-term safety and efficacy of a once-daily niacin/lovastatin formulation for patients with dyslipidemia
ML Kashyap et al.
AMERICAN JOURNAL OF CARDIOLOGY (2002)
Clinical inertia
LS Phillips et al.
ANNALS OF INTERNAL MEDICINE (2001)
Coadministration of colesevelam hydrochloride with atorvastatin lowers LDL cholesterol additively
D Hunninghake et al.
ATHEROSCLEROSIS (2001)
Low-dose combination therapy with colesevelam hydrochloride and lovastatin effectively decreases low-density lipoprotein cholesterol in patients with primary hypercholesterolemia
MH Davidson et al.
CLINICAL CARDIOLOGY (2001)
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
JI Cleeman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia
HH Knapp et al.
AMERICAN JOURNAL OF MEDICINE (2001)
Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial
TJ Smilde et al.
LANCET (2001)
Factors associated with low compliance with lipid-lowering drugs in hyperlipidemic patients
DN Kiortsis et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2000)
Noncholesterol sterols and cholesterol lowering by long-term simvastatin treatment in coronary patients - Relation to basal serum cholestanol
TA Miettinen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
The Lipid Treatment Assessment Project (L-TAP) -: A multicenter survey to evaluate the percentages of dyslipidemic, patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals
TA Pearson et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Current perspectives on statins
DJ Maron et al.
CIRCULATION (2000)
分享论文
